BioPlus Acquisition Net Income

BioPlus Acquisition posts a net income of $12M as of June 2023. That compares with $38K in the prior-year period — up 31469.2% year over year. That is below the sector sector average of $86M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioPlus Acquisition's net income was $38K. The latest reading is $12M — a 31469.2% year-over-year increase (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a net income near $86M is typical. BioPlus Acquisition's $12M is lower that level. That is roughly 86.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Net Income is one piece of BioPlus Acquisition's financial statement story. At $12M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BIOS's net income usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $86M), and (3) consistency with growth and profitability. This page covers the first two; BioPlus Acquisition's other metric pages and overview cover the third.